The short answer
One cannabis-based medicine has FDA approval for epilepsy in children: purified cannabidiol, marketed as Epidiolex. It is cleared for seizures linked to Dravet syndrome and Lennox-Gastaut syndrome in patients 2 years and older, and for tuberous sclerosis complex in patients 1 year and older. It is a prescription product, dosed by body weight, and usually added to whatever anti-seizure medications a child already takes. No dispensary flower, vape, edible, or artisanal CBD oil holds that approval for pediatric use.
medical cannabis for children with epilepsy
What the evidence supports
The strongest pediatric evidence comes from randomized, double-blind, placebo-controlled trials of purified CBD. In the 2017 New England Journal of Medicine trial, children and young adults with Dravet syndrome who added CBD to standard treatment saw convulsive seizure frequency fall from a median of about 12 per month to roughly 6, while the placebo group dropped far less. Trials in Lennox-Gastaut syndrome showed similar reductions in drop seizures, and a later study in tuberous sclerosis complex followed the same pattern.
Pediatric Medical Cannabis Laws and Costs by State
Three things stand out in that body of work:
Finding a Pediatric Medical Cannabis Specialist Doctor Near You
- The medicine was a single molecule, CBD, not a plant extract with unknown ratios.
- Doses were fixed and titrated on a schedule, with bloodwork monitoring.
- Every child stayed on their existing anti-seizure drugs.
Cannabis did not replace neurology care in these trials. It sat alongside it.
Top Pick: Medical Cannabis for Pediatric Cancer Treatment
What the evidence does not support
Most "medical cannabis for epilepsy" claims at the retail level rest on parent surveys, case reports, and small open-label studies. Those are worth reading, but they cannot separate a real drug effect from placebo, from changes in other medications, or from the natural swings of a seizure disorder. A Cochrane review of cannabis-based medicines for epilepsy found the randomized evidence limited to purified CBD, with no reliable data backing whole-plant products in children.
Variable products are a real problem. A bottle labeled 20:1 CBD to THC can contain anywhere from a trace to a meaningful amount of THC, and potency labels in some states have been shown to miss by wide margins. For a child, an unpredictable dose is a safety issue, not a minor detail.
Why THC is a different conversation for kids
THC is the compound that produces a high, and it acts on developing brain circuits. Pediatric neurologists tend to avoid it outside of tightly controlled research settings. Concerns include effects on attention, memory, and mood during a stretch of rapid brain development, plus a practical problem: a child who cannot describe how they feel cannot report side effects. Families sometimes ask about high-THC products after reading about adult patients. That is a question for the child's epilepsy team, not a call made at a dispensary counter.
Side effects and interactions to expect
CBD is not harmless just because it comes from a plant. In trials, the most common side effects were sleepiness, reduced appetite, diarrhea, and fatigue. A minority of children had elevated liver enzymes, which is why baseline and periodic liver blood tests matter. That risk climbs when CBD is combined with valproate.
Interactions are the larger issue. CBD inhibits several CYP450 enzymes and can raise blood levels of clobazam and its active metabolite, which is one reason some children become sedated during titration. It can also interact with valproate, everolimus, and other drugs. Dose changes should be slow and supervised for that reason.
What a careful path looks like
- Start with a pediatric neurologist or an epilepsy center, not a dispensary.
- Ask specifically about FDA-approved CBD and whether the child's seizure type and syndrome fit the label.
- Get baseline liver function tests and a full medication review for interactions.
- Titrate slowly, one change at a time, so you can tell what is doing what.
- Keep a seizure diary with type, duration, and rescue medication use. It is the only way to judge whether something is working.
Questions to bring to the care team
- Does my child's diagnosis fall under an approved indication?
- Which current medications could interact, and what monitoring is needed?
- What does a realistic response look like, and how long before we judge it?
- Which side effects would mean stopping or adjusting the dose?
- If we try a product without FDA approval, what are the risks and how would you track them?
A note on dispensary products
Adult patients use cannabis for many reasons, and state-legal shops serve them. Children are a different category. Without standardized dosing, independent testing, and a prescriber overseeing the plan, a dispensary product cannot be treated as medicine for a child with epilepsy. If a family wants to explore cannabis-based treatment, the route runs through a neurologist and, where appropriate, an FDA-approved prescription.